NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) Latest Filing Signal

Latest Filing: 10-Q  |  Filed Feb 13, 2026

Cross-checked across multiple AI analysts and grounded in the latest SEC filing.

powered by: earningsVibe.ai

Question:
What is the latest filing signal for NATURAL ALTERNATIVES INTERNATIONAL INC?
Answer:
Based on earningsVibe SuperAnalyst™ synthesis of the latest 10-Q, NATURAL ALTERNATIVES INTERNATIONAL INC's filing signal turned positive.
earningsVibe SuperAnalyst™ Verdict: TURNED POSITIVE

Signal Performance — Stock Price Since Filing

30-Day Change
-24.07%
from filing date
60-Day Change
Pending
from filing date

Underlying analyst views from Perplexity, Gemini, Claude, and ChatGPT

PERPLEXITY
Continuing Negative
GEMINI
Turned Positive
CLAUDE
Turned Positive
CHATGPT
Continuing Negative

Unlock the Full Filing Analysis

See full earningsSig™ and risksSig™ analysis across 5,000+ companies

Get Started Free →

No credit card required

Question:
What does NATURAL ALTERNATIVES INTERNATIONAL INC actually do?
Answer:
Natural Alternatives International (NAI) is a leading formulator, manufacturer, and marketer of nutritional supplements, operating through two primary segments: private-label contract manufacturing and patent/trademark licensing. The company leverages its scientific research, proprietary ingredients, and regulatory expertise to provide comprehensive services to its customers, which include companies marketing vitamins, minerals, herbs, and other health products. NAI's proprietary patent estate for beta-alanine, commercialized under trademarks like CarnoSyn(R) and SR CarnoSyn(R), is a key differentiator, generating direct sales and licensing revenue. With manufacturing facilities in California and Switzerland, NAI serves a global customer base, emphasizing quality certifications and strategic partnerships to drive growth.
Question:
What are NATURAL ALTERNATIVES INTERNATIONAL INC's revenue drivers?
Answer:
Revenue is primarily driven by private-label contract manufacturing services for nutritional supplements and health products, alongside sales and licensing of its proprietary beta-alanine ingredients (CarnoSyn(R), SR CarnoSyn(R), TriBsynTM).

Cut through noisy SEC filings to find the signal faster

Source-grounded filing intelligence with one-click links back to the filing, so you can move faster and verify everything at the source.

Get Started Free →

No credit card required